A total of 137 actinomycetes cultures, isolated from 25 different herbal vermicomposts, were characterized for their antagonistic potential against Fusarium oxysporum f. sp. ciceri (FOC) by dual-culture assay. Of the isolates, five most promising FOC antagonistic isolates were characterized for the production of siderophore, cellulase, protease, hydrocyanic acid (HCN), indole acetic acid (IAA) and antagonistic potential against Rhizoctonia bataticola, which causes dry root rot in chickpea (three strains viz. RB-6, RB-24 and RB-115) and sorghum (one strain). All of the five FOC antagonistic isolates produced siderophore and HCN, four of them (except KAI-90) produced IAA, KAI-32 and KAI-90 produced cellulase and CAI-24 and CAI-127 produced protease. In the dual-culture assay, three of the isolates, CAI-24, KAI-32 and KAI-90, also inhibited all three strains of R. bataticola in chickpea, while two of them (KAI-32 and KAI-90) inhibited the lonely strain in sorghum. When the FOC antagonistic isolates were evaluated further for their antagonistic potential in the greenhouse and wilt-sick field conditions on chickpea, 45-76% and 4-19% reduction of disease incidence were observed, respectively compared to the control. The sequences of 16S rDNA gene of the isolates CAI-24, CAI-121, CAI-127, KAI-32 and KAI-90 were matched with Streptomyces tsusimaensis, S. caviscabies, S. setonii, S.africanus and an identified species of Streptomyces, respectively using the BLAST searching. This study indicated that the selected actinomycete isolates have the potential for biological control of Fusarium wilt disease in chickpea.
A total of 360 bacteria, isolated from the rhizospheres of a system of rice intensification (SRI) fields, were characterized for the production of siderophore, fluorescence, indole acetic acid (IAA), hydrocyanic acid (HCN) and solubilization of phosphorus. Of them, seven most promising isolates and -360) were screened for their antagonistic potential against Macrophomina phaseolina (causes charcoal rot in sorghum) by dual culture assay, blotter paper assay and in greenhouse.All the seven isolates inhibited M. phaseolina in dual culture assay, whereas six isolates solubilized phosphorous (except SRI-360), all seven produced siderophore, four produced fluorescence (except SRI-178, -229 and -305), six produced IAA (except SRI-305) and five produced HCN (except SRI-158 and -305). In the blotter paper assay, no charcoal rot infection was observed in SRI-156-treated sorghum roots, indicating complete inhibition of the pathogen, while the roots treated with the other isolates showed 49−76% lesser charcoal rot infection compared to the control. In the antifungal activity test (in green house on sorghum), all the isolates increased shoot dry mass by 15−23% and root dry mass by 15−20% (except SRI-158 and -360), over the control. In order to confirm the plant growthpromoting (PGP) traits of the isolates, the green house experiment was repeated but, in the absence of M. phaseolina. The results further confirmed the PGP traits of the isolates as evidenced by increases in shoot and root dry mass, 22−100% and 5−20%, respectively, over the control. The sequences of 16S rDNA gene of the isolates were matched with Pseudomonas plecoglossicida, Brevibacterium antiquum, Bacillus altitudinis, Enterobacter ludwigii, E. ludwigii, Acinetobacter tandoii and P. monteilii, respectively in BLAST analysis. This study indicates that the selected bacterial isolates have the potential for PGP and control of charcoal rot disease in sorghum.3
A total of 137 actinomycetes, isolated from 25 different herbal vermicomposts, were characterized for their antagonistic potential against Macrophomina phaseolina by dual-culture assay. Of them, eight most promising isolates (CAI-17, CAI-21, CAI-26, CAI-68, CAI-78, KAI-26, KAI-27 and MMA-32) were characterized for the production of siderophore, chitinase, protease, hydrocyanic acid (HCN), indole acetic acid (IAA) and further evaluated for their antagonistic potential against M. phaseolina by blotterpaper assay and in greenhouse. All the eight isolates produced HCN and IAA, seven produced siderophore (except CAI-78) and protease (except KAI-27) and four produced chitinase (CAI-26, KAI-26, KAI-27 and MMA-32). In the blotter-paper assay, no charcoal-rot infection was observed in KAI-26 and KAI-27-treated sorghum roots, indicating complete inhibition of the pathogen, while the other isolates showed 47 to 88% lesser charcoal-rot infection compared to the control. In the antifungal activity test against M. phaseolina (in greenhouse on sorghum), all the isolates increased in shoot dry mass by 28 to 53% and root dry mass by 5 to 21%, over the control. In order to confirm the plant growth promoting (PGP) traits of the isolates, the green house experiment was repeated, but in the absence of M. phaseolina. The results further confirmed the PGP traits of the isolates as evidenced by 15 to 34% increase in shoot dry mass on six isolates (except CAI-26 and KAI-27), 14 to 57% increase in root dry mass on five isolates (except CAI-68, KAI-26 and KAI-27), 17 to 60% increase in root length on five isolates (except CAI-17, CAI-21 and CAI-68) and 10 to 64% increase in root volume on six isolates (except CAI-17 and CAI-68). Culture filtrate of three potential actinomycetes (CAI-21, CAI-26 and MMA-32) at 0.5% inhibited the growth of M. phaseolina, indicating that the metabolites of these actinomycetes were responsible for the inhibition. The sequences of 16S rDNA gene of the isolates matched with Streptomyces but with different species in BLAST analysis. This study indicates that the selected actinomycetes have the potential for PGP and control of charcoal-rot disease in sorghum.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.